Selected research
Industry Research
Ambulatory Polysomnography (Psg) System Industry Research Report 2026
Market perspective
The global Ambulatory Polysomnography (Psg) System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ambulatory Polysomnography (Psg) System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ambulatory Polysomnography (Psg) System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ambulatory Polysomnography (Psg) System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ambulatory Polysomnography (Psg) System include Natus Embla, Compumedics, Neurosoft, Cadwell Industries, Philips, Löwenstein Medical, Nihon Kohden, Nox Medical and Somnomedics AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ambulatory Polysomnography (Psg) System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ambulatory Polysomnography (Psg) System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ambulatory Polysomnography (Psg) System Market by Company
Natus Embla
Compumedics
Neurosoft
Cadwell Industries
Philips
Löwenstein Medical
Nihon Kohden
Nox Medical
Somnomedics AG
Advanced Brain Monitoring (ABM)
DEYMED Diagnostic
Hangzhou NeuroTrace
Beijing BMC Medical
Hunan VentMed Medical Technology
Hangzhou Lucky Day Medical Technology
Ambulatory Polysomnography (Psg) System Segment by Type
＜10-Channel
≥10-Channel
Ambulatory Polysomnography (Psg) System Segment by Application
Hospital
Home
Others
Ambulatory Polysomnography (Psg) System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Polysomnography (Psg) System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Polysomnography (Psg) System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Polysomnography (Psg) System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ambulatory Polysomnography (Psg) System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ＜10-Channel
- ≥10-Channel
Applications
- Hospital
- Home
- Others
Companies covered
- Natus Embla
- Compumedics
- Neurosoft
- Cadwell Industries
- Philips
- Löwenstein Medical
- Nihon Kohden
- Nox Medical
- Somnomedics AG
- Advanced Brain Monitoring (ABM)
- DEYMED Diagnostic
- Hangzhou NeuroTrace
- Beijing BMC Medical
- Hunan VentMed Medical Technology
- Hangzhou Lucky Day Medical Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ambulatory Polysomnography (Psg) System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ＜10-Channel
- 2.2.3 ≥10-Channel
- 2.3 Ambulatory Polysomnography (Psg) System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Home
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Ambulatory Polysomnography (Psg) System Breakdown Data by Type
- 3.1 Global Ambulatory Polysomnography (Psg) System Historic Market Size by Type (2021-2026)
- 3.2 Global Ambulatory Polysomnography (Psg) System Forecasted Market Size by Type (2027-2032)
4 Ambulatory Polysomnography (Psg) System Breakdown Data by Application
- 4.1 Global Ambulatory Polysomnography (Psg) System Historic Market Size by Application (2021-2026)
- 4.2 Global Ambulatory Polysomnography (Psg) System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ambulatory Polysomnography (Psg) System Market Perspective (2021-2032)
- 5.2 Global Ambulatory Polysomnography (Psg) System Growth Trends by Region
- 5.2.1 Global Ambulatory Polysomnography (Psg) System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ambulatory Polysomnography (Psg) System Historic Market Size by Region (2021-2026)
- 5.2.3 Ambulatory Polysomnography (Psg) System Forecasted Market Size by Region (2027-2032)
- 5.3 Ambulatory Polysomnography (Psg) System Market Dynamics
- 5.3.1 Ambulatory Polysomnography (Psg) System Industry Trends
- 5.3.2 Ambulatory Polysomnography (Psg) System Market Drivers
- 5.3.3 Ambulatory Polysomnography (Psg) System Market Challenges
- 5.3.4 Ambulatory Polysomnography (Psg) System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ambulatory Polysomnography (Psg) System Players by Revenue
- 6.1.1 Global Top Ambulatory Polysomnography (Psg) System Players by Revenue (2021-2026)
- 6.1.2 Global Ambulatory Polysomnography (Psg) System Revenue Market Share by Players (2021-2026)
- 6.2 Global Ambulatory Polysomnography (Psg) System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ambulatory Polysomnography (Psg) System Head Office and Area Served
- 6.4 Global Ambulatory Polysomnography (Psg) System Players, Product Type & Application
- 6.5 Global Ambulatory Polysomnography (Psg) System Manufacturers Established Date
- 6.6 Global Ambulatory Polysomnography (Psg) System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
- 7.2 North America Ambulatory Polysomnography (Psg) System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ambulatory Polysomnography (Psg) System Market Size by Country (2021-2026)
- 7.4 North America Ambulatory Polysomnography (Psg) System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
- 8.2 Europe Ambulatory Polysomnography (Psg) System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ambulatory Polysomnography (Psg) System Market Size by Country (2021-2026)
- 8.4 Europe Ambulatory Polysomnography (Psg) System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
- 9.2 Asia-Pacific Ambulatory Polysomnography (Psg) System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ambulatory Polysomnography (Psg) System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ambulatory Polysomnography (Psg) System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
- 10.2 South America Ambulatory Polysomnography (Psg) System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ambulatory Polysomnography (Psg) System Market Size by Country (2021-2026)
- 10.4 South America Ambulatory Polysomnography (Psg) System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
- 11.2 Middle East & Africa Ambulatory Polysomnography (Psg) System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ambulatory Polysomnography (Psg) System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ambulatory Polysomnography (Psg) System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Natus Embla
- 12.1.1 Natus Embla Company Information
- 12.1.2 Natus Embla Business Overview
- 12.1.3 Natus Embla Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.1.4 Natus Embla Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.1.5 Natus Embla Recent Developments
- 12.2 Compumedics
- 12.2.1 Compumedics Company Information
- 12.2.2 Compumedics Business Overview
- 12.2.3 Compumedics Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.2.4 Compumedics Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.2.5 Compumedics Recent Developments
- 12.3 Neurosoft
- 12.3.1 Neurosoft Company Information
- 12.3.2 Neurosoft Business Overview
- 12.3.3 Neurosoft Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.3.4 Neurosoft Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.3.5 Neurosoft Recent Developments
- 12.4 Cadwell Industries
- 12.4.1 Cadwell Industries Company Information
- 12.4.2 Cadwell Industries Business Overview
- 12.4.3 Cadwell Industries Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.4.4 Cadwell Industries Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.4.5 Cadwell Industries Recent Developments
- 12.5 Philips
- 12.5.1 Philips Company Information
- 12.5.2 Philips Business Overview
- 12.5.3 Philips Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.5.4 Philips Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.5.5 Philips Recent Developments
- 12.6 Löwenstein Medical
- 12.6.1 Löwenstein Medical Company Information
- 12.6.2 Löwenstein Medical Business Overview
- 12.6.3 Löwenstein Medical Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.6.4 Löwenstein Medical Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.6.5 Löwenstein Medical Recent Developments
- 12.7 Nihon Kohden
- 12.7.1 Nihon Kohden Company Information
- 12.7.2 Nihon Kohden Business Overview
- 12.7.3 Nihon Kohden Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.7.4 Nihon Kohden Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.7.5 Nihon Kohden Recent Developments
- 12.8 Nox Medical
- 12.8.1 Nox Medical Company Information
- 12.8.2 Nox Medical Business Overview
- 12.8.3 Nox Medical Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.8.4 Nox Medical Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.8.5 Nox Medical Recent Developments
- 12.9 Somnomedics AG
- 12.9.1 Somnomedics AG Company Information
- 12.9.2 Somnomedics AG Business Overview
- 12.9.3 Somnomedics AG Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.9.4 Somnomedics AG Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.9.5 Somnomedics AG Recent Developments
- 12.10 Advanced Brain Monitoring (ABM)
- 12.10.1 Advanced Brain Monitoring (ABM) Company Information
- 12.10.2 Advanced Brain Monitoring (ABM) Business Overview
- 12.10.3 Advanced Brain Monitoring (ABM) Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.10.4 Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.10.5 Advanced Brain Monitoring (ABM) Recent Developments
- 12.11 DEYMED Diagnostic
- 12.11.1 DEYMED Diagnostic Company Information
- 12.11.2 DEYMED Diagnostic Business Overview
- 12.11.3 DEYMED Diagnostic Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.11.4 DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.11.5 DEYMED Diagnostic Recent Developments
- 12.12 Hangzhou NeuroTrace
- 12.12.1 Hangzhou NeuroTrace Company Information
- 12.12.2 Hangzhou NeuroTrace Business Overview
- 12.12.3 Hangzhou NeuroTrace Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.12.4 Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.12.5 Hangzhou NeuroTrace Recent Developments
- 12.13 Beijing BMC Medical
- 12.13.1 Beijing BMC Medical Company Information
- 12.13.2 Beijing BMC Medical Business Overview
- 12.13.3 Beijing BMC Medical Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.13.4 Beijing BMC Medical Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.13.5 Beijing BMC Medical Recent Developments
- 12.14 Hunan VentMed Medical Technology
- 12.14.1 Hunan VentMed Medical Technology Company Information
- 12.14.2 Hunan VentMed Medical Technology Business Overview
- 12.14.3 Hunan VentMed Medical Technology Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.14.4 Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.14.5 Hunan VentMed Medical Technology Recent Developments
- 12.15 Hangzhou Lucky Day Medical Technology
- 12.15.1 Hangzhou Lucky Day Medical Technology Company Information
- 12.15.2 Hangzhou Lucky Day Medical Technology Business Overview
- 12.15.3 Hangzhou Lucky Day Medical Technology Revenue in Ambulatory Polysomnography (Psg) System Business (2021-2026)
- 12.15.4 Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
- 12.15.5 Hangzhou Lucky Day Medical Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst